• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,822.91 -0.29
(0.00%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
346.4234695
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
138.04
8167.46
EPS(TTM)
Face Value()
Div & Yield %
6.42
10
0.45
 

urja global ltd
Ushdev International reports consolidated net loss of Rs 0.74 crore in the March 2025 quarter
May 30,2025
Net Loss of Ushdev International reported to Rs 0.74 crore in the quarter ended March 2025 as against net loss of Rs 4.81 crore during the previous quarter ended March 2024. Sales remain constant at Rs 1.48 crore in the quarter ended March 2025 and also during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 16.45 crore in the year ended March 2025 as against net loss of Rs 9.74 crore during the previous year ended March 2024. Sales declined 17.96% to Rs 12.33 crore in the year ended March 2025 as against Rs 15.03 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales1.481.48 0 12.3315.03 -18
OPM %45.95-56.76 --95.30-28.48 -
PBDT1.02-3.04 LP -9.31-2.59 -259
PBT-0.74-4.81 85 -16.45-9.74 -69
NP-0.74-4.81 85 -16.45-9.74 -69